Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea

Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea Outside a Level III Maternity Hospital in Alsace

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05150301

Acronym

OutBorn

Enrollment

134

Registered

2021-12-09

Start date

2021-11-01

Completion date

2022-10-30

Last updated

2021-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth

Keywords

Premature Birth, Outborn, Newborns, Gestational age

Brief summary

An outborn birth is a premature birth that occurs in an unsuitable level center at the end of the child (unlike inborn births). This study aims to describe the morbidity and mortality of very premature newborns (gestational age less than 32 weeks of amenorrhea) born outside a maternity hospital of appropriate level between January 1, 2016 and December 31, 2020, and assessment of the preventable or non-preventable nature of these so-called outborn births. The aim of this research is to write down the short-term mortality and morbidity of newborns born at a gestational age \<32 weeks of amenorrhea outside a level III maternity hospital in Alsace between January 1, 2016 and December 31, 2020.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

32 Weeks to No maximum

Healthy volunteers

Inclusion criteria

\- Newborn under 32 weeks of amenorrhea at the time of birth, born in Alsace in one of the level I, IIa, or IIb maternity hospitals, between January 1, 2016 and December 31, 2020

Exclusion criteria

\- Fetal death in utero

Design outcomes

Primary

Measure	Time frame
Study of the short-term mortality and morbidity of newborns born at a gestational age <32 weeks of amenorrhea	Files analysed retrospectively from January 01, 2016 to December 31, 2010 will be examined]

Countries

France

Contacts

Primary ContactBenoit ESCANDE, MD

benoit.escande@chru-strasbourg.fr33 3 88 12 77 93

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr

Outcome results